“…Polymeric biomaterials have been utilized as advanced drug carriers [ 23 , 24 , 25 , 26 , 27 ], because their properties can be controlled by small changes in environmental conditions [ 24 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 ], to improve therapeutic efficacy and minimize undesirable side effects [ 36 , 37 , 38 , 39 , 40 , 41 ]. Among the various polymeric biomaterials, pH-sensitive polymers have been developed as promising drug carriers for pH-dependent drug release in distinctive tumor microenvironments, such as tumor extracellular pH (pH ex , ranging from 6.5 to 7.2) and endosomal pH (pH en ≤ 6.5) [ 32 , 42 , 43 , 44 , 45 , 46 ]. In particular, nanocarriers based on pH-sensitive biomaterials have shown outstanding in vitro and in vivo tumor inhibition by higher drug release.…”